- Home
- DOW vs TEVA Comparison
DOW vs TEVA Comparison
Compare DOW & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOW
- TEVA
- Stock Information
- Founded
- DOW 1897
- TEVA 1901
- Country
- DOW United States
- TEVA Israel
- Employees
- DOW N/A
- TEVA N/A
- Industry
- DOW Major Chemicals
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- DOW Industrials
- TEVA Health Care
- Exchange
- DOW Nasdaq
- TEVA Nasdaq
- Market Cap
- DOW 19.0B
- TEVA 18.8B
- IPO Year
- DOW N/A
- TEVA N/A
- Fundamental
- Price
- DOW $21.79
- TEVA $15.40
- Analyst Decision
- DOW Hold
- TEVA Strong Buy
- Analyst Count
- DOW 15
- TEVA 7
- Target Price
- DOW $30.87
- TEVA $24.71
- AVG Volume (30 Days)
- DOW 17.7M
- TEVA 12.4M
- Earning Date
- DOW 07-24-2025
- TEVA 07-30-2025
- Dividend Yield
- DOW 6.42%
- TEVA N/A
- EPS Growth
- DOW N/A
- TEVA N/A
- EPS
- DOW N/A
- TEVA N/A
- Revenue
- DOW $41,819,000,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- DOW N/A
- TEVA $5.19
- Revenue Next Year
- DOW $2.95
- TEVA $0.16
- P/E Ratio
- DOW N/A
- TEVA N/A
- Revenue Growth
- DOW N/A
- TEVA 2.08
- 52 Week Low
- DOW $21.79
- TEVA $12.47
- 52 Week High
- DOW $55.67
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- DOW 28.22
- TEVA 35.34
- Support Level
- DOW $24.37
- TEVA $16.24
- Resistance Level
- DOW $26.13
- TEVA $17.24
- Average True Range (ATR)
- DOW 1.07
- TEVA 0.50
- MACD
- DOW -0.65
- TEVA -0.06
- Stochastic Oscillator
- DOW 0.00
- TEVA 17.96
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.